Lotus Pharmaceutical Co., Ltd. (1795.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 73.65B |
| Enterprise Value | 121.85B |
| P/E Ratio | 12.01 |
| PEG Ratio | -0.55 |
| Price/Sales Ratio | 1.6 |
| Price/Book Ratio | 1.86 |
| Enterprise/Revenue | 3.43 |
| Enterprise/EBITDA | 10.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 20.51B |
| Revenue/Share | 109.56 |
| Gross Profit | 10.64B |
| EBITDA | 7.44B |
| Net Income | 4.72B |
| Diluted EPS | 18.04 |
Balance Sheet
| Total Cash | 6.33B |
| Total Cash/Share | 24.33 |
| Total Debt | 58.45B |
| Total Debt/Equity | 2.4 |
| Current Ratio | 1.46 |
| Book Value Per Share | 93.48 |
Price History
| 52-Week Change | -6.72 |
| 52-Week High | 364.76 |
| 52-Week Low | 168.31 |
| Moving Average 50 Days | 187.52 |
| Moving Average 200 Days | 232.17 |
Statistics
| Average Volume | 1.6M |
| Shares Outstanding | 262.81M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.57 |
| Trailing Annual Dividend Yield | 1.48 |
| Payout Ratio | 0.4 |
| Last Split Factor | 1013:1000 |
| Last Split Date | August 31, 2026 |
AD
